Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06831526
What this trial is testing

Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Washington University School of Medicine 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04485949
What this trial is testing

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

Who this might be right for
Glioblastoma
Imvax 99
Early research (Phase 1)Ended earlyNCT02722512
What this trial is testing

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

Who this might be right for
Glioblastoma MultiformeAstrocytoma, Grade IIIAnaplastic Ependymoma+2 more
Ann & Robert H Lurie Children's Hospital of Chicago 10
Testing effectiveness (Phase 2)Ended earlyNCT00052715
What this trial is testing

Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 31
Testing effectiveness (Phase 2)Study completedNCT03137888
What this trial is testing

Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
Emory University 30
Early research (Phase 1)Study completedNCT03867123
What this trial is testing

Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients

Who this might be right for
Glioblastoma (GBM)
Laminar Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT00731731
What this trial is testing

Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 125
Early research (Phase 1)Study completedNCT00693095
What this trial is testing

Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer

Who this might be right for
Glioblastoma
John Sampson 23
Early research (Phase 1)Study completedNCT00639639
What this trial is testing

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Malignant Neoplasms of Brain
Gary Archer Ph.D. 42
Testing effectiveness (Phase 2)Looking for participantsNCT05084430
What this trial is testing

Study of Pembrolizumab and M032 (NSC 733972)

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaGliosarcoma
University of Alabama at Birmingham 28
Testing effectiveness (Phase 2)Looking for participantsNCT05768919
What this trial is testing

Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas

Who this might be right for
Glioblastoma
SignPath Pharma, Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT03603405
What this trial is testing

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Who this might be right for
GlioblastomaAnaplastic Astrocytoma
The Methodist Hospital Research Institute 62
Early research (Phase 1)Looking for participantsNCT07089641
What this trial is testing

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Who this might be right for
GlioblastomaGlioblastoma, IDH-WildtypeGliosarcoma+3 more
Jonsson Comprehensive Cancer Center 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT05100641
What this trial is testing

AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM

Who this might be right for
Primary Glioblastoma
Aivita Biomedical, Inc. 672
Testing effectiveness (Phase 2)Active Not RecruitingNCT02455557
What this trial is testing

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
Roswell Park Cancer Institute 66
Not applicableStudy completedNCT03276286
What this trial is testing

Nativis Voyager for Newly Diagnosed GBM

Who this might be right for
Glioblastoma Multiforme
Nativis, Inc. 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07389278
What this trial is testing

Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)

Who this might be right for
GlioblastomaHigh-Grade Glioma (WHO III-IV)High-grade Glioma+2 more
Sabine Mueller, MD, PhD 97
Testing effectiveness (Phase 2)Study completedNCT01285414
What this trial is testing

Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Myrexis Inc. 5
Testing effectiveness (Phase 2)Study completedNCT00005952
What this trial is testing

Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorHead and Neck Cancer+5 more
Duke University 30
Early research (Phase 1)Study completedNCT00650923
What this trial is testing

Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 61
Next Page